Methimazole protects lungs during hepatic ischemia-reperfusion injury in rats: An effect not induced by hypothyroidism

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 5, 2007, Pages 704-709

  Tütüncü, Tanju ^a   Demirci, Çagatay ^a   Gözalan, Ugur ^a   Yüksek, Yunus Nadi ^a   Bilgihan, Ayse ^b   Kama, Nuri Aydin ^a,c  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c Uzmanlar Tip Grubu   (Turkey)

Author keywords

Hypothyroidism; Ischemia reperfusion; Lung; Malondialdehyde; Methimazole

Indexed keywords

LEVOTHYROXINE; MALONALDEHYDE; MYELOPEROXIDASE; THIAMAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; HYPOTHYROIDISM; LIVER ISCHEMIA; LUNG INJURY; LUNG LOBECTOMY; LUNG PARENCHYMA; LUNG PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RANDOMIZATION; RAT; REPERFUSION INJURY; THYROIDECTOMY; WISTAR RAT;

EID: 34247236606     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04202.x     Document Type: Article

References (34)

1. Kimura N, Muraoka R, Horiuchi T et al. Intermittent hepatic pedicle clamping reduces liver and lung injury. J. Surg. Res. 1998; 78: 11-17.
2. Meyer K, Brown MF, Zibari G et al. ICAM-1 upregulation in distant tissues after hepatic ischemia-reperfusion: a clue to the mechanism of multiple organ failure. J. Pediatr. Surg. 1998; 33: 350-3.
3. Weinbroum A, Rudick V, Kluger Y, Karchevsky E, Graf E, Vidne BA. Multiple organ dysfunction after remote circulatory arrest: common pathway of radical oxygen species? J. Trauma 1999; 47: 691-8.
4. Carrick JB, Martins O Jr, Snider CC et al. The effect of LPS on cytokine syntesis and lung neutrophil influx after hepatic I/R injury in the rat. J. Surg. Res. 1997; 68: 16-23.
5. Nakamitsu A, Hiyama E, Imamura Y, Matsuura Y, Yokoyama T. Kupffer cell function in ischemic and nonischemic livers after hepatic partial ischemia/reperfusion. Surg. Today 2001; 31: 140-8.
6. Coletti LM, Burtch GD, Remick DG et al. The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia-reperfusion. Transplantation 1990; 49: 268-72.
7. Wanner GA, Ertel W, Muller P et al. Liver ischemia-reperfusion induces a systemic inflammatory response through Kuppfer cell activation. Shock 1996; 5: 34-40.
8. Peralta C, Prats N, Xaus C, Gelpi E, Rosello-Catafau J. Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat. Hepatology 1999; 30: 1481-9.
9. Meduri GU, Headley S, Kohler G et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995; 107: 1062-73.
10. Roumen RM, Hendriks T, Van der Ven-Jongekrijg J et al. Cytokine patterns in patient after major vascular surgery, hemorrhagic shock and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann. Surg. 1993; 218: 769-76.
11. Imberti R, Vairetti M, Gualea MR et al. The effect of thyroid hormone modulation on rat liver injury associated with ischemia-reperfusion and cold storage. Anesth. Analg. 1998; 86: 1187-93.
12. Shirin H, Dotan I, Papa M et al. Inhibition of concanavalin A-induced acute T cell dependent hepatic damage in mice by hypothyroidism. Liver 1999; 19: 206-11.
13. Maliekal TT, Sudha B. Kinetic parameters of thymidine kinase and DNA synthesis during liver regeneration: role of thyroid hormones. Life Sci. 1997; 60: 1867-74.
14. Oren R, Dotan I, Papa M et al. Inhibition of experimentally induced cirrhosis in rats by hypothyroidism. Hepatology 1996; 24: 419-23.
15. Lechpammer M, Lukac J, Lechpammer S, Kusic Z. Antithyroid drug-induced immunomodulation in Graves' disease patients. Acta Med. Croatica 2002; 56: 21-6.
16. Hasegawa M, Abe M, Ohnishi K, Shoji C, Ishikawa O. Clinical usefulness of a long-term treatment with an antithyroid drug for psoriasis vulgaris. J. Dermatol. 2004; 31: 794-7.
17. Guerra LN, Rios de Molina Mdel C, Miler EA, Moiguer S, Karner M, Burdman JA. Antioxidants and methimazole in the treatment of Graves' disease: effect on urinary malondialdehyde levels. Clin. Chim. Acta 2005; 352: 115-20.
18. Rojter S, Tessler J, Alvarez D et al. Vasodilatory effects of propylthiouracil in patients with alcoholic cirrhosis. J. Hepatol. 1995; 22: 184-8.
19. Orrego H, Blake JE, Blendis LM, Compton KV, Volpe R, Israel Y. Long-term treatment of alcoholic liver disease with propylthiouracil. Part 2: Influence of drop-out rates and of continued alcohol consumption in a clinical trial. J. Hepatol. 1994; 20: 343-9.
20. Balazs C, Kiss E, Leovey A, Farid NR. The immunosuppressive effect of metimazole on cell-mediated immunity is mediated by its capacity to inhibit peroxidase and to scavenge free oxygen radicals. Clin. Endocrinol. 1986; 25: 7-16.
21. Liu WK. Effect of methimazole-induced hypothyroidism on alveolar macrophages. Virchows Arch. B Cell Pathol. Mol. Pathol. 1991; 60: 21-6.
22. Weetman AP. Effect of the anti-thyroid drug methimazole on interleukin-1 and interleukin-2 levels in vitro. Clin. Endocrinol. 1986; 25: 133-42.
23. Horiuchi T, Muraoka R, Tabo T, Uchinami M, Kimura N, Tanigawa N. Optimal cycles of hepatic ischemia and reperfusion for intermittent pedicle clamping during liver surgery. Arch. Surg. 1995; 130: 754-8.
24. Peng XX, Currin RT, Thurman RG, Lemasters JJ. Protection by pentoxifylline against normothermic liver ischemia/reperfusion in rats. Transplantation 1995; 59: 1537-41.
25. McCord JM. Oxygen-derived radicals: a link between reperfusion injury and inflammation. Federation Proc. 1987; 46: 2402-6.
26. Venditti P, De Rosa R, Di Meo S. Effect of thyroid state on H2O2 production by rat liver mitochondria. Mol. Cell Endocrinol. 2003; 205: 185-92.
27. Diehl AM. Regulation of liver injury and repair. Immunol. Rev. 2000; 174: 160-71.
28. Adkins A, Hollwarth ME, Benoit JN, Parks DA. Role of free radicals in ischemia-reperfusion injury to the liver. Acta. Physiol. Scand. Suppl. 1986; 548: 101-7.
29. Rotstein OD. Oxidants and antioxidant therapy. Crit. Care Clin. 2001; 17: 239-47.
30. Roden E, Lima L, Lucas M et al. The effect of allopurinol in hepatic I/R. Eur. Surg. Res. 2000; 32: 215-22.
31. Atalla S, Toledo L, MacKenzie C, Cederna J. Influence of oxygen-derived free radical scavengers on ischemic livers. Transplantation 1985; 40: 584-90.
32. Marubayashi S, Dohi K, Ochi K, Kawasaki T. Role of free radicals in ischemic rat liver cell injury. Surgery 1986; 99: 184-92.
33. Oren R, Maaravi Y, Karmeli F et al. Anti-thyroid drugs decrease mucosal damage in a rat model of experimental colitis. Aliment. Pharmacol. Ther. 1997; 11: 341-5.
34. Bruck R, Oren R, Shirin H et al. Hypothyroidism minimizes liver damage and improves survival in rats with thioacetamide induced fulminant hepatic failure. Hepatology 1998; 4: 1013-20.